Trastuzumab plus docetaxel with or without capecitabine as first-line therapy for HER2-positive locally advanced or metastatic breast cancer: a randomised Phase II study
2008 ◽
Vol 6
(7)
◽
pp. 109-110
◽
Keyword(s):
Phase Ii
◽